PRMT5 and cancer: Protein arginine methyltransferase 5 (PRMT5) is a druggable enzyme that has been shown to be aberrantly expressed in various cancers, and it acts as a putative oncogene in maintaining cancer cell survival [7–9], yet its role in OS remains elusive.